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EVIDENCE B R I E F
Family Planning Financing 
POLICY AND PROGRAMME 
CONSIDERATIONS
 Ensure sustained fundraising, 
pooling, and strategic 
purchasing in order to scale 
up delivery systems for 
contraceptive methods. 
 Increase the number of 
additional family planning users 
by reaching new users and 
improving continuation rates 
among current users. 
 Conduct further research 
on family planning quality 
performance metrics, such 
as the method information 
index, to test their correlation 
with higher continuation 
rates. Client dissatisfaction 
and discontinuation represent 
significant risks to the success 
of FP2020.
FAMILY PLANNING
HEALTH CLINIC, SOUTH AFRICA
  Ensuring Adequate Financing of Family 
Planning Commodities and Services
Increasing efficient and effective investment in family planning through 
the public and private sectors is key to meeting the FP2020 goal of 
helping 120 million additional women become modern contraceptive 
users. Despite efforts by country governments, donors and individuals 
are responsible for nearly half (49%) of the costs of reproductive, 
maternal, neonatal, and children’s health (1). Household expenditures 
dwarf the contributions of both domestic and international funding 
sources. Future efforts to reduce unmet need for FP must consider 
consumers’ out-of-pocket costs, programmatic cost-effectiveness, and 
sources of funding.  
CHALLENGES TO FINANCING  
FAMILY PLANNING 
The estimated direct and indirect annual cost of providing modern 
contraceptive services to 671 million users in developing regions is 
US$6.3 billion (2). Direct costs include contraceptives, supplies, and 
health worker salaries. Indirect costs include programme support, 
information and education on FP, construction and maintenance of 
facilities, and supply chain management. This results in a total average 
(including direct and indirect) cost for modern contraception per person 
per year in developing regions of US$1.01. 
Expanding and improving services to meet the needs of all women 
and girls in developing regions (an additional 214 million) for modern 
contraception would cost US$12 billion annually (including direct and 
indirect) or US$1.93 per person per year (2). 
The average cost per person in developing regions for modern contra-
ceptive services and maternal and newborn care is US$8.56 or US$53.6 
billion annually (2). Investing in both contraceptive and maternal and 
newborn services together results in a net savings of $6.9 billion com-
pared with investing in maternal and newborn health care alone.
If current trends in increased contraceptive use in 148 developing 
countries and territories continue, there will be a funding gap of US$322 
million in 2020 for commodities alone (2). If the FP2020 goal were fully 
achieved, the remaining funding gap between amounts spent on supplies 
in 2014 and 2020 would be US$541 million (3).
Resources from donors have increased over time, with the 
US historically being the largest bilateral donor followed by 
the UK (3). In 2015, the US contributed nearly half (47%) of 
the bilateral funding for FP, contributing US$638 million, 
and the UK contributed US$269.9 million (20%) (4). 
There are also multilateral sources of funding, with the 
UNFPA spending about 43% of its funds or US$341 million 
on FP in 2015 and the World Bank spending US$251 million 
on population and reproductive health. (4). Following the 
creation of the Global Financing Facility (GFF), the World 
Bank is expected to have a greater role in FP (4). 
Foundations and the private sector have also made sizeable 
contributions to reproductive health, with the Bill & Melinda 
Gates Foundation, for example, spending US$148 million for 
family planning in 2015 (4). And pharmaceutical companies 
have played a role in partnership with donors through 
innovative financing mechanisms that have seen significant 
reductions in the price of contraceptives – most notably by 
Bayer and Merck for contraceptive implants. 
However, the outlook for future donor funding is uncertain 
given the instability in currency exchange rates, changing 
donor-country political agendas, creation of the GFF, and 
other global developments. The 2018 US budget withheld 
contribution to UNFPA and level funded family planning, 
however significant reductions are planned in 2017 (4).
Moreover, domestic funding commitments are highly 
variable between countries. Domestic financing will likely 
require more engagement of ministries of finance as well 
as ministries of health to emphasize the demographic 
dividend. The demographic dividend is an increase 
in economic growth and development that could be 
achieved if changes in the population age structure 
result in declining fertility rates as a result of increased 
contraceptive use coupled with investments to improve 
education, job creation, efficiency in revenue generation 
and tax collection, and increased tax rates (1). Greater 
integration of public and private sectors in service delivery, 
pooling of procurement, and strategic purchasing will lead 
to more efficient and higher per capita spending with more 
consistent investment. Serving women and hard-to-reach 
populations in low-income countries requires an integrated 
approach to strengthening health systems in order to move 
toward universal health coverage (1).
CONSIDERATIONS FOR ENSURING 
ADEQUATE FINANCING OF  
FAMILY PLANNING COMMODITIES 
AND SERVICES
Increasing the number of additional FP users is 
achieved both by reaching new users and by improving 
continuation rates among current users (5,6). Further 
research on FP quality performance metrics, such 
as the method information index, is needed to test 
their correlation with improved continuation rates. 
Particularly as contraceptive prevalence increases, client 
dissatisfaction and discontinuation represent a significant 
risk to the success of the FP2020 initiative (7).
Achieving universal access to family planning would 
have one of the highest benefit-cost ratios among a 
wide choice of policy options for development (8). 
Social and economic benefits for women, their families, 
and societies will result from increases in women’s and 
children’s education, increases in women’s earnings, and 
further reductions in poverty (2). In health, prevention 
is much cheaper than treatment; the cost of modern 
contraception is much lower than providing care for 
unintended pregnancies. For each additional dollar spent 
on FP above the current level, the cost of pregnancy-
related care in developing regions is reduced by US$2.20 
(2). If needs for modern contraception and maternal 
and newborn care were fully met, the result would be a 
net savings of US$6.9 billion compared with investing in 
maternal and newborn health care alone (2). Investing 
in modern contraception will provide a great return on 
investment that compounds over time (12). 
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This is one of seven Family Planning Evidence Briefs  
prepared for the Family Planning Summit held in London on 
July 11, 2017. The briefs highlight evidence and provide research 
and programme considerations for improving access to family 
planning and reducing unintended pregnancy. Programme 
considerations are based on the expert views of the authors, who 
undertook desk reviews drawing on existing evidence.
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